QHSLab Inc Class A USAQ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if USAQ is a good fit for your portfolio.
News
-
QHSLab, Inc. Announces Preliminary Unaudited First Quarter Revenue Results
-
QHSLab Announces Impressive 2023 Fiscal Year Results with Growing Revenues, Improved Gross Margins, and Substantial Reduction in Net Loss
-
QHSLab Integrates Digital Medicine Assessments into Prominent Electronic Health Record (EHR) Company
Trading Information
- Previous Close Price
- $0.09
- Day Range
- $0.07–0.09
- 52-Week Range
- $0.02–0.25
- Bid/Ask
- $0.06 / $0.09
- Market Cap
- $919,395.72
- Volume/Avg
- 8,313 / 33,300
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.60
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. The company is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- —
- Total Number of Employees
- 4
- Website
- https://www.qhslab.com
Valuation
|
Metric
|
USAQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.60 |
Price/Cash Flow | — |
Price/Earnings
USAQ
Financial Strength
|
Metric
|
USAQ
|
|---|---|
Quick Ratio | 0.06 |
Current Ratio | 0.08 |
Interest Coverage | −1.03 |
Quick Ratio
USAQ
Profitability
|
Metric
|
USAQ
|
|---|---|
Return on Assets (Normalized) | −25.50% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −15.37% |
Return on Assets
USAQ
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Fxkfbsvp | Cjymyw | $185.4 Bil | |
SYK
| Stryker Corp | Rtkjmckjw | Wsgm | $128.2 Bil | |
BSX
| Boston Scientific Corp | Yqdnvrs | Pyfhcgm | $107.7 Bil | |
MDT
| Medtronic PLC | Btgdkwft | Mjgjlld | $105.2 Bil | |
DXCM
| DexCom Inc | Dmdjbsnvgx | Sxlds | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Pdhjxrds | Rzgsz | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Rmztcxzk | Wwfs | $24.6 Bil | |
ALGN
| Align Technology Inc | Nhhyxnyq | Njnxh | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Nrdvrzrcr | Yyqbscl | $18.7 Bil | |
PODD
| Insulet Corp | Rlygzcrwx | Kzclw | $11.5 Bil |